Analytical Data
-
Gene name
CDCA7
- Application
-
Alternative Names
CDCA7; JPO1Cell division cycle-associated Protein 7; Protein JPO1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BWT1
-
Expression Region
1-371aa
-
AA Sequence
MDARRVPQKDLRVKKNLKKFRYVKLISMETSSSSDDSCDSFASDNFANTRLQSVREGCRTRSQCRHSGPLRVAMKFPARSTRGATNKKAESRQPSENSVTDSNSDSEDESGMNFLEKRALNIKQNKAMLAKLMSELESFPGSFRGRHPLPGSDSQSRRPRRRTFPGVASRRNPERRARPLTRSRSRILGSLDALPMEEEEEEDKYMLVRKRKTVDGYMNEDDLPRSRRSRSSVTLPHIIRPVEEITEEELENVCSNSREKIYNRSLGSTCHQCRQKTIDTKTNCRNPDCWGVRGQFCGPCLRNRYGEEVRDALLDPNWHCPPCRGICNCSFCRQRDGRCATGVLVYLAKYHGFGNVHAYLKSLKQEFEMQA
-
Molecular Weight
69 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDCA7 (Cell Division Cycle Associated 7) is a protein that plays a pivotal role in regulating cell cycle progression and is implicated in various cellular processes, including proliferation and apoptosis. Research has highlighted its potential involvement in tumorigenesis, as altered expression levels of CDCA7 have been observed in several types of cancers. The study of CDCA7, particularly in the form of recombinant proteins, is significant for understanding its functional mechanisms and interactions within the cell. Recombinant CDCA7 can be produced using advanced biotechnology techniques, allowing researchers to investigate its biochemical properties, structural features, and role in signaling pathways. Such studies are invaluable for elucidating the protein's contribution to cancer biology and for identifying potential therapeutic targets. Furthermore, understanding CDCA7’s interactions with other cellular proteins can provide insights into its role in the regulation of gene expression and signal transduction, thereby opening avenues for developing targeted cancer therapies. Overall, the recombinant CDCA7 research not only enhances our understanding of cell cycle regulation but also holds promise for future clinical applications in oncology.
